Precision Optics Corp Inc/Mass (POCI)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$4.35-0.46%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
Broken: Primary pillar broken — Revenue growth to at least $8.7M in Q3 2026: metric not reported.
Precision Optics is growing revenue from $6.7M to $8.7M in recent quarters. Gross profit improved from $0.95M to $2.06M, showing better margins. The company focuses on strategic initiatives to drive growth. Capital allocation remains a concern but is being addressed.
The company is still loss-making with negative free cash flow. Recent COO departure and debt issuance raise risks. Revenue growth and margin gains may stall or reverse. Market selloff reflects these concerns.
The price is about 51% below our fair value near $10. Analysts expect 19.5% revenue growth, which is priced in. Our view aligns with this but remains cautious given losses and risks.
Breaks if: material negative capital allocation events or worsening financial instability
Breaks if: gross profit falls below $0.95M in any quarter through 2026-Q3
Breaks if: quarterly revenue falls below $6.7M in any quarter through 2026-Q3
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround scenario with a focus on improving revenue and margins. The current thesis state is intact, but the company is loss-making and has a high risk profile.
The market appears to be pricing in a low expectations gap, suggesting that POCI is seen as cheap compared to its peers. However, the overall valuation reflects a justified stance given its recent performance and the challenges ahead.
Management is on track with initiatives to increase revenue and improve gross profit margins, as evidenced by recent financial performance. However, there is an elevated risk of missing earnings expectations in the near term, which could impact sentiment.
The thesis hinges on the company's ability to maintain guidance and navigate potential economic headwinds. Key factors include the performance of sector bellwethers and overall market conditions, particularly in the healthcare sector.
In the next 1 to 3 years, POCI's performance will depend on its execution of strategic initiatives and external economic factors. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.